Omentin associates with serum metabolite profiles indicating lower diabetes risk: KORA F4 Study

Introduction Circulating omentin levels have been positively associated with insulin sensitivity. Although a role for adiponectin in this relationship has been suggested, underlying mechanisms remain elusive. In order to reveal the relationship between omentin and systemic metabolism, this study aim...

Full description

Saved in:
Bibliographic Details
Main Authors: Barbara Thorand, Annette Peters, Wolfgang Rathmann, Michael Roden, Christian Herder, Jerzy Adamski, Cornelia Prehn, Rui Wang-Sattler, Karsten Suhre, Jacqueline M Ratter-Rieck, Mengya Shi
Format: Article
Language:English
Published: BMJ Publishing Group 2024-04-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/12/2/e003865.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850059969987084288
author Barbara Thorand
Annette Peters
Wolfgang Rathmann
Michael Roden
Christian Herder
Jerzy Adamski
Cornelia Prehn
Rui Wang-Sattler
Karsten Suhre
Jacqueline M Ratter-Rieck
Mengya Shi
author_facet Barbara Thorand
Annette Peters
Wolfgang Rathmann
Michael Roden
Christian Herder
Jerzy Adamski
Cornelia Prehn
Rui Wang-Sattler
Karsten Suhre
Jacqueline M Ratter-Rieck
Mengya Shi
author_sort Barbara Thorand
collection DOAJ
description Introduction Circulating omentin levels have been positively associated with insulin sensitivity. Although a role for adiponectin in this relationship has been suggested, underlying mechanisms remain elusive. In order to reveal the relationship between omentin and systemic metabolism, this study aimed to investigate associations of serum concentrations of omentin and metabolites.Research design and methods This study is based on 1124 participants aged 61–82 years from the population-based KORA (Cooperative Health Research in the Region of Augsburg) F4 Study, for whom both serum omentin levels and metabolite concentration profiles were available. Associations were assessed with five multivariable regression models, which were stepwise adjusted for multiple potential confounders, including age, sex, body mass index, waist-to-hip ratio, lifestyle markers (physical activity, smoking behavior and alcohol consumption), serum adiponectin levels, high-density lipoprotein cholesterol, use of lipid-lowering or anti-inflammatory medication, history of myocardial infarction and stroke, homeostasis model assessment 2 of insulin resistance, diabetes status, and use of oral glucose-lowering medication and insulin.Results Omentin levels significantly associated with multiple metabolites including amino acids, acylcarnitines, and lipids (eg, sphingomyelins and phosphatidylcholines (PCs)). Positive associations for several PCs, such as diacyl (PC aa C32:1) and alkyl-alkyl (PC ae C32:2), were significant in models 1–4, whereas those with hydroxytetradecenoylcarnitine (C14:1-OH) were significant in all five models. Omentin concentrations were negatively associated with several metabolite ratios, such as the valine-to-PC ae C32:2 and the serine-to-PC ae C32:2 ratios in most models.Conclusions Our results suggest that omentin may influence insulin sensitivity and diabetes risk by changing systemic lipid metabolism, but further mechanistic studies investigating effects of omentin on metabolism of insulin-sensitive tissues are needed.
format Article
id doaj-art-24c47b4eeb7a49d8a33ed39a442f5c56
institution DOAJ
issn 2052-4897
language English
publishDate 2024-04-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Diabetes Research & Care
spelling doaj-art-24c47b4eeb7a49d8a33ed39a442f5c562025-08-20T02:50:44ZengBMJ Publishing GroupBMJ Open Diabetes Research & Care2052-48972024-04-0112210.1136/bmjdrc-2023-003865Omentin associates with serum metabolite profiles indicating lower diabetes risk: KORA F4 StudyBarbara Thorand0Annette Peters1Wolfgang Rathmann2Michael Roden3Christian Herder4Jerzy Adamski5Cornelia Prehn6Rui Wang-Sattler7Karsten Suhre8Jacqueline M Ratter-Rieck9Mengya Shi10Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), Pettenkofer School of Public Health, Faculty of Medicine, Ludwig-Maximilians-Universität, Munich, GermanyInstitute for Medical Information Processing, Biometry and Epidemiology, Ludwig-Maximilians-Universität München, Munich, GermanyGerman Center for Diabetes Research, Partner Düsseldorf, Neuherberg, GermanyInstitute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine-University Düsseldorf, Düsseldorf, GermanyGerman Center for Diabetes Research (DZD), Partner Düsseldorf, Düsseldorf, GermanyInstitute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, SloveniaMetabolomics and Proteomics Core, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, GermanyInstitute of Translational Genomics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, GermanyDepartment of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Doha, QatarInstitute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine-University Düsseldorf, Düsseldorf, GermanyTUM School of Medicine and Health, Technical University of Munich (TUM), Munich, GermanyIntroduction Circulating omentin levels have been positively associated with insulin sensitivity. Although a role for adiponectin in this relationship has been suggested, underlying mechanisms remain elusive. In order to reveal the relationship between omentin and systemic metabolism, this study aimed to investigate associations of serum concentrations of omentin and metabolites.Research design and methods This study is based on 1124 participants aged 61–82 years from the population-based KORA (Cooperative Health Research in the Region of Augsburg) F4 Study, for whom both serum omentin levels and metabolite concentration profiles were available. Associations were assessed with five multivariable regression models, which were stepwise adjusted for multiple potential confounders, including age, sex, body mass index, waist-to-hip ratio, lifestyle markers (physical activity, smoking behavior and alcohol consumption), serum adiponectin levels, high-density lipoprotein cholesterol, use of lipid-lowering or anti-inflammatory medication, history of myocardial infarction and stroke, homeostasis model assessment 2 of insulin resistance, diabetes status, and use of oral glucose-lowering medication and insulin.Results Omentin levels significantly associated with multiple metabolites including amino acids, acylcarnitines, and lipids (eg, sphingomyelins and phosphatidylcholines (PCs)). Positive associations for several PCs, such as diacyl (PC aa C32:1) and alkyl-alkyl (PC ae C32:2), were significant in models 1–4, whereas those with hydroxytetradecenoylcarnitine (C14:1-OH) were significant in all five models. Omentin concentrations were negatively associated with several metabolite ratios, such as the valine-to-PC ae C32:2 and the serine-to-PC ae C32:2 ratios in most models.Conclusions Our results suggest that omentin may influence insulin sensitivity and diabetes risk by changing systemic lipid metabolism, but further mechanistic studies investigating effects of omentin on metabolism of insulin-sensitive tissues are needed.https://drc.bmj.com/content/12/2/e003865.full
spellingShingle Barbara Thorand
Annette Peters
Wolfgang Rathmann
Michael Roden
Christian Herder
Jerzy Adamski
Cornelia Prehn
Rui Wang-Sattler
Karsten Suhre
Jacqueline M Ratter-Rieck
Mengya Shi
Omentin associates with serum metabolite profiles indicating lower diabetes risk: KORA F4 Study
BMJ Open Diabetes Research & Care
title Omentin associates with serum metabolite profiles indicating lower diabetes risk: KORA F4 Study
title_full Omentin associates with serum metabolite profiles indicating lower diabetes risk: KORA F4 Study
title_fullStr Omentin associates with serum metabolite profiles indicating lower diabetes risk: KORA F4 Study
title_full_unstemmed Omentin associates with serum metabolite profiles indicating lower diabetes risk: KORA F4 Study
title_short Omentin associates with serum metabolite profiles indicating lower diabetes risk: KORA F4 Study
title_sort omentin associates with serum metabolite profiles indicating lower diabetes risk kora f4 study
url https://drc.bmj.com/content/12/2/e003865.full
work_keys_str_mv AT barbarathorand omentinassociateswithserummetaboliteprofilesindicatinglowerdiabetesriskkoraf4study
AT annettepeters omentinassociateswithserummetaboliteprofilesindicatinglowerdiabetesriskkoraf4study
AT wolfgangrathmann omentinassociateswithserummetaboliteprofilesindicatinglowerdiabetesriskkoraf4study
AT michaelroden omentinassociateswithserummetaboliteprofilesindicatinglowerdiabetesriskkoraf4study
AT christianherder omentinassociateswithserummetaboliteprofilesindicatinglowerdiabetesriskkoraf4study
AT jerzyadamski omentinassociateswithserummetaboliteprofilesindicatinglowerdiabetesriskkoraf4study
AT corneliaprehn omentinassociateswithserummetaboliteprofilesindicatinglowerdiabetesriskkoraf4study
AT ruiwangsattler omentinassociateswithserummetaboliteprofilesindicatinglowerdiabetesriskkoraf4study
AT karstensuhre omentinassociateswithserummetaboliteprofilesindicatinglowerdiabetesriskkoraf4study
AT jacquelinemratterrieck omentinassociateswithserummetaboliteprofilesindicatinglowerdiabetesriskkoraf4study
AT mengyashi omentinassociateswithserummetaboliteprofilesindicatinglowerdiabetesriskkoraf4study